South Region CCG Mental Health Masterclass - EIP Preparedness ProgrammeSarah Amani
The Early Intervention in Mental Health Network's mission is to improve health and social outcomes for young people with first episode psychosis, including symptom reduction and engagement with education and employment.
This document is the beginning of a programme to help people work together in preparation of the regions task to achieve the above mission.
Early Intervention: Improving Access to Mental Health by 2020 [Presentations]Sarah Amani
Most mental illnesses begin in adolescence or early adulthood – the vital time in life when we establish our independence. Mental illness can derail this process with long-lasting effects. We know that the earlier we can engage a young person in treatment the better their outcomes – but young people are the least likely to seek help from mental health services. This is not helped by the separation of services at age 18.
The good news is that we know that early intervention makes a difference in getting young people well and keeping them well. Early intervention teams have been established for psychosis in England for the last 12 years. Psychosis is a serious mental illness affecting 1-2% of the population, with about 500 new cases every year in the Oxford AHSN area.
Early intervention in psychosis is a specialist, community-based service providing medical, psychological and family-based treatments. It helps get young people back to work or education and keeps an eye out for any early signs of relapse so that they can be prevented. Early intervention teams are highly valued by young people and their families. They also save the health service money by keeping people well and getting them back to work.
The Early intervention in mental health network will make sure that this best practice is in place across the Oxford AHSN region with the highest standard of care provided everywhere. We also aim to spread this early intervention model across other conditions (such as eating disorders, personality disorder, autistic spectrum conditions) to help more young people.
World class research is being undertaken in Oxford AHSN and across England into early psychosis – both into the causes and to trial new treatments. We aim to make this research available to every patient being seen by our early intervention teams. We will also look to develop new innovations and technologies that could improve the experience of young people receiving mental healthcare.
An overview of the work carried out by NHS England and NHS Improving Quality's Long Term Conditions Sustainable Improvement Team. It puts the case for why person-centred care has to be at the heart of healthcare.
Slides from a lunch and learn webinar hosted by NHS England's Long Term Conditions Team, on the topic of health coaching by lay professionals.
The speakers and Anya de Longh and Jim Phillips.
Commissioning Integrated models of care
Kent LTC Year of Care Commissioning Early Implementer Site
Alison Davis, Integration Programme Health and Social Care, Working on behalf of Kent County Council and South Kent Coast and Thanet CCG's
Presented by: David Cozadd, Director of Operations with the Burke Center
Thomas Kerss, Sheriff of Nacogdoches County; Current President of the Sheriff’s Association for Texas
Anne Bondesen, Project Director for the Rural East Texas Health Network (RETHN)
İnovatif Kimya Dergisi Sayı-16 Anlatılan Konu Başlıkları
HPLC ve İlaç Sanayinde Uygulamaları
Proteinlerin Yapıtaşı Aminoasitler
Kendi Kendini Temizleyen Biyolojik Yüzeyler
Biyoplastikler
Vampirlerin Korkulu Rüyası Sarımsak
Gazların Difüzyonu
Hyperchem ile Molekül Modelleme-1
Ayrıca Her Ay 3 Web Sitesi ve Kimya Bulmacası, Kimya Sektöründen Haberler, Kimya Sözlüğü ile Element Tanıyalım
İyi okumalar dileriz.
South Region CCG Mental Health Masterclass - EIP Preparedness ProgrammeSarah Amani
The Early Intervention in Mental Health Network's mission is to improve health and social outcomes for young people with first episode psychosis, including symptom reduction and engagement with education and employment.
This document is the beginning of a programme to help people work together in preparation of the regions task to achieve the above mission.
Early Intervention: Improving Access to Mental Health by 2020 [Presentations]Sarah Amani
Most mental illnesses begin in adolescence or early adulthood – the vital time in life when we establish our independence. Mental illness can derail this process with long-lasting effects. We know that the earlier we can engage a young person in treatment the better their outcomes – but young people are the least likely to seek help from mental health services. This is not helped by the separation of services at age 18.
The good news is that we know that early intervention makes a difference in getting young people well and keeping them well. Early intervention teams have been established for psychosis in England for the last 12 years. Psychosis is a serious mental illness affecting 1-2% of the population, with about 500 new cases every year in the Oxford AHSN area.
Early intervention in psychosis is a specialist, community-based service providing medical, psychological and family-based treatments. It helps get young people back to work or education and keeps an eye out for any early signs of relapse so that they can be prevented. Early intervention teams are highly valued by young people and their families. They also save the health service money by keeping people well and getting them back to work.
The Early intervention in mental health network will make sure that this best practice is in place across the Oxford AHSN region with the highest standard of care provided everywhere. We also aim to spread this early intervention model across other conditions (such as eating disorders, personality disorder, autistic spectrum conditions) to help more young people.
World class research is being undertaken in Oxford AHSN and across England into early psychosis – both into the causes and to trial new treatments. We aim to make this research available to every patient being seen by our early intervention teams. We will also look to develop new innovations and technologies that could improve the experience of young people receiving mental healthcare.
An overview of the work carried out by NHS England and NHS Improving Quality's Long Term Conditions Sustainable Improvement Team. It puts the case for why person-centred care has to be at the heart of healthcare.
Slides from a lunch and learn webinar hosted by NHS England's Long Term Conditions Team, on the topic of health coaching by lay professionals.
The speakers and Anya de Longh and Jim Phillips.
Commissioning Integrated models of care
Kent LTC Year of Care Commissioning Early Implementer Site
Alison Davis, Integration Programme Health and Social Care, Working on behalf of Kent County Council and South Kent Coast and Thanet CCG's
Presented by: David Cozadd, Director of Operations with the Burke Center
Thomas Kerss, Sheriff of Nacogdoches County; Current President of the Sheriff’s Association for Texas
Anne Bondesen, Project Director for the Rural East Texas Health Network (RETHN)
İnovatif Kimya Dergisi Sayı-16 Anlatılan Konu Başlıkları
HPLC ve İlaç Sanayinde Uygulamaları
Proteinlerin Yapıtaşı Aminoasitler
Kendi Kendini Temizleyen Biyolojik Yüzeyler
Biyoplastikler
Vampirlerin Korkulu Rüyası Sarımsak
Gazların Difüzyonu
Hyperchem ile Molekül Modelleme-1
Ayrıca Her Ay 3 Web Sitesi ve Kimya Bulmacası, Kimya Sektöründen Haberler, Kimya Sözlüğü ile Element Tanıyalım
İyi okumalar dileriz.
Alcohol related liver disease: prevention and prediction by Professor Nick Sh...Health Innovation Wessex
**Please note: Professor Nick Sheron retains the copyright to these slides. If you wish to use the content further, please email Nick.Sheron@soton.ac.uk for advice and guidance**
This presentation was delivered at Wessex AHSN's 2016 conference - Predict, Prevent, Adapt.
Midlands and East GP Forward View update event May 2017NHS England
A presentation from the GP Forward View update event in May 2017 for Midlands and East, giving the latest information on what the Forward View is delivering.
What Does Commissioning and Quality Improvement Mean to Me?Sarah Amani
This was a good question which got me thinking: there are so many buzz words in healthcare sometimes its good to unpack what we mean. As one of the areas I cover, Cornwall and the Isles of Scilly are of huge importantance and interest to me so I was really happy to be invited to meet with their impressive commissioning and quality improvement team to discuss this topic
How will Sustainability and Transformation Plans (STPs) help deliver the Five Year Forward View?
Matthew Swindells and Simon Enright, NHS England, and Julia Ross, North West Surrey CCG
Day One, Pop-up University 7, 10.00
Over recent years, acute hospital emergency care pathways have come under increasing pressure due to a variety of factors. The symptoms of this are often overcrowded A&E departments, overfull hospitals and sometimes a poor experience for patients and staff.
Supporting the NHS to tackle this is a priority for NHS IQ. We recognise that to do this requires a collaborative approach, to connect and work with partners from across the emergency care landscape to deliver targeted and tailored local support, along with large scale system-wide change in primary, community and secondary care.
Master slide deck from the Excel in Health webinar series: The NHS landscape presentation.
This webinar identifies the structure of the NHS and its national priorities.
The session will cover the following topics:
Understand the structure of the NHS
Understand the national priorities of the NHS
Recognise the barriers to sale
Similar to Mental Health Summit 7 June 2016 Presentation 4 (20)
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Reducing opioid prescribing, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Pharmacist Interventions and Medication Reviews at Care Homes - Improving Med...Health Innovation Wessex
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Pharmacist Interventions and Medication Reviews at Care Homes - Improving Medication Safety and Patient Outcomes, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, SBAR Patient Engagement Tool, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Reducing medication related falls risk in patients with severe frailty, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Assessing the outcomes of structured medication reviews, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Polypharmacy SMR reviews in outpatient bone health clinics, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Polypharmacy reviews of asthma and COPD patients over 65 and 10 or more medic...Health Innovation Wessex
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Polypharmacy reviews of asthma and COPD patients over 65 and 10 or more medicines, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Evaluating the impact of a specialist frailty multidisciplinary team pathway ...Health Innovation Wessex
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Evaluating the impact of a specialist frailty multidisciplinary team pathway with clinical pharmacist involvement, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Genome UK – State of the nation by Professor Dame Sue Hill, Chief Scientific Officer for England and NHS Genomics Programme Senior Responsible Officer.
Pharmacogenomics into practice - stroke services and a systems approach by Dr Richard Marigold, Consultant Stroke Physician and NIHR Hyperacute Stroke Research Centre Lead, University Hospital Southampton NHS Foundation Trust
To evaluate the benefits of Structured Medication Reviews in elderly Chinese ...Health Innovation Wessex
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, To evaluate the benefits of Structured Medication Reviews in elderly Chinese patients, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary,
Review of patients on high dose opioids at Living Well PCN, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Re-establishing autonomy in elderly frail patients, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Improving Medication Reviews using the NO TEARS Tool, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Improving care in County Durham under the STOMP agenda - A 5 year review.pdfHealth Innovation Wessex
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Improving care in County Durham under the STOMP agenda - A 5 year review, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Impact of an EMIS search to prioritise care home residents for a pharmacist l...Health Innovation Wessex
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Impact of an EMIS search to prioritise care home residents for a pharmacist led medication review, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Identifying Orthostatic Hypotension caused by Medication, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Mental Health Summit 7 June 2016 Presentation 4
1. www.england.nhs.uk
Karen Turner
Director of Mental Health Clinical Policy and Strategy
NHS England
Mental Health Summit
7 June 2016, Southampton
Five Year Forward View
for Mental Health:
From planning to delivery
2. The report in a nutshell:
• 20,000+ people engaged
• Designed for and with the NHS Arms’ Length Bodies
• All ages (building on Future in Mind)
• Three key themes in the strategy:
o High quality 7-day services for people in crisis
o Integration of physical and mental health care
o Prevention
• Plus ‘hard wiring the system’ to support good mental
health care across the NHS wherever people need it
• Focus on targeting inequalities
• 58 recommendations for the NHS and system partners
• £1bn additional NHS investment by 2020/21 to help an
extra 1 million people of all ages
• Recommendations for NHS accepted in full and
endorsed by government
Five Year Forward View for Mental Health
Prime Minister: “The Taskforce has set out
how we can work towards putting mental
and physical healthcare on an equal footing
and I am committed to making sure that
happens.”
Simon Stevens: “Putting mental and
physical health on an equal footing will
require major improvements in 7 day
mental health crisis care, a large increase
in psychological treatments, and a more
integrated approach to how services are
delivered. That’s what today's taskforce
report calls for, and it's what the NHS is
now committed to pursuing.”
2
3. Wessex CYPMH Services 2013/14
An outline for the Wessex CN Children’s Mental Health Service is presented below. Data
was taken from the 2015 Local Transformation Plans and compares Wessex to the
England Average in Mental Health Prevalence, Expenditure and Referrals.
Approximate 5-16 year olds with a diagnosable Mental Health per
1000 children
Approximate Annual Total CYPMH Referrals per 1000 0-17 general
population 2013/14
Approximate Annual total CYPMH expenditure per 1000 0-17 general
population £’000s 2013/14
Thames ValleyWessex
9 CCGs
19.7%
Population aged 0-17 years
9.6% estimated 5-16 year olds
with mental health condition
Accepted
referrals
England
28.38
23.9823.9
18
0
5
10
15
20
25
30
Total referrals per
1000 0-17 general
population
Accepted referrals per
1000 0-17 general
population
Wessex
England
3
4. Wessex 64% 88% 80% 83% 80% 73% 46% 73%
Clinical Network ↓ Participation Whole System Promotion
Vulnerable
Groups
Outcomes
Eating
Disorders
Workforce AVERAGE
AVERAGE by THEME 72% 88% 63% 60% 76% 70% 42% 67%
Overview of Wessex CAMHS Local Transformation Plans
• NEL CSU scored plans using the themes set out in Future in Mind and Eating Disorders.
Wessex scored very highly based on the information provided in the LTPs – however workforce
planning is a concern .
• The information that has been delivered in the trackers from the CCGs in the region is much
weaker.
4
5. LTP Area 2014-15
CCG
spend
reported
in LTPs
(‘000)
2014-15
Local
Authority
Spend
reported
in LTPs
(‘000)
Total
funds
allocated
in 2015-
16 (ED
and
Spring
Budget )
Spring
Budget
Information
reported in Q4
tracker for
generic
capacity
building
Increase in CYP
access to
generic CAMHS
Portsmouth £2,396 £241 £266,297 £154,050 1 FTE 1,478
Southampto
n
£3,622 Unknown £295,253 £170,800 2.0 FTE 2,500
Isle of Wight £1,619 £277 £175,230 £101,369 0 FTE 1
Hampshire £8,910 £1,746 £1,613,41
0
£933,337 0 FTE 0
Dorset Unknow
n
£584 £1,015,75
0
£587,600 8.5 FTE 800
Capacity Building and Spend in CYP MH Services – Q4 information using the
resources from the Spring Budget
5
6. LTP Area 2014-15
CCG
spend
reported
in LTPs
(‘000)
2014-15
Local
Authority
Spend
reported
in LTPs
(‘000)
Total funds
allocated in
2015-16 (ED
and Spring
Budget )
Eating
Disorder
monies
Information
reported in Q4
tracker for
eating
disorders
capacity
building
Increase in CYP
with access to
treatment for
eating disorder
Portsmouth £2,396 £241 £266,297 £122,247 5 FTE 32
Southampton £3,622 Unknown £295,253 £124,453 2.2 FTE 0
Isle of Wight £1,619 £277 £175,230 £73,861 0 FTE 1
Hampshire £8,910 £1,746 £1,613,410 £933,337 4.2 FTE 5
Dorset Unknown £584 £1,015,750 £680,070 8.0 FTE 80
• The Isle of Wight report that they are currently meeting the Access and Wait Standard for Eating
Disorders and seeing 91.7% of eating disorder cases within 4 weeks
• All other LTPs plan to use the new money to reach this target
Capacity Building and Spend in Eating Disorder Services – Q4 information
6
7. • Total investment from 2015/16 to 2020/21 £365m (Government announced £290m
Jan 2016, building on earlier spring budget announcement).
• February 2016: Mental Health Task Force’s 5YFV for MH recommends additional
investment so that by 2020/21, an additional 30,000 women in all areas of the
country should receive access to evidenced-based specialist support, closer to their
home, when they need it, including access to psychological therapies and right
range of specialist community or inpatient care.
• Enables NHS England to design a phased, five-year transformation programme to
build capacity and capability in specialist perinatal mental health services, with the
aim of enabling women in all areas of England to access NICE-concordant care by
2020/21.
Perinatal Mental Health – Key Announcements
7
8. 2016/17 2018/19 2019/20 2020/212017/18
Preparation and planning: pathways,
networks, workforce development
Building capacity in MBUs
Securing transformation:
• Building capacity in specialist community teams
• Rolling out new model of care for MBUs
• Data, metrics and payment levers
Five year phasing
8
9. • Governance and accountability – national project board launched in April to oversee
implementation delivery with all system partners and develop five-year programme
• Developing MBU provision
• Complete procurement of three new units (South West, North West and East of England)
• Complete existing capacity review and build any additional beds into contracts
• Continued investment in implementation teams and perinatal mental health networks
• Launch and delivery of clinical leadership bursaries
• Workforce and development – support HEE to develop workforce strategy to identify
requirements, training events and development of a tiered skills and competency framework.
• Support for commissioners in planning future requirements through analytics and seminars.
National priorities 2016/17
9
10. • Develop and build effective multiprofessional clinical networks, with leaders from
across the care pathway, to drive service improvement, promote clinical excellence
and support professional development.
• Identify and assess baseline positions in terms of availability and access to specialist
perinatal mental health services (gap analysis in line with NICE guidance) in order to
determine strategic plans for coming years and respond to availability of new
funding.
• Ensure that a broad range of perinatal mental health support is available locally, with
clear pathways available for identification and timely access to psychological
therapies and specialist perinatal services in line with NICE guidance.
• Establish local workforce strategies to inform and deliver the 5 year vision.
• Collaborate between the regional networks and share good practice – including the
Wessex network’s exciting innovation ‘WebBeds’.
Network priorities 2016/17
10
11. “By 2020, there should be 24-hour access to mental
health crisis care, 7 days a week, 365 days a year –
a ‘7 Day NHS for people’s mental health’.”
11
• over £400m for crisis resolution and home
treatment teams (CRHTTs) to deliver 24/7
treatment in communities and homes as a
safe and effective alternative to hospitals
(over 4 years from 2017/18);
• £247m for liaison mental health services in every hospital emergency
department (over 4 years from 2017/18);
• £15m for Health Based Places of Safety in 2016/17 (non-recurrent)
Spending Review – Headlines for Crisis & Acute Care
12. Recommendation 17:
• By 2020/21 24/7 community crisis response across all
areas that are adequately resourced to offer intensive
home treatment, backed by investment in CRHTTs.
• Equivalent model to be developed for CYP
Recommendation 18:
• By 2020/21, no acute hospital is without all-age mental
health liaison services in emergency departments and
inpatient wards
• At least 50 per cent of acute hospitals are meeting the
‘core 24’ service standard as a minimum by 2020/21.
12
Mental Health Forward View – crisis & acute
recommendations (1/2)
13. Recommendation 22:
• Introduce standards for acute mental health care, with the expectation that
care is provided in the least restrictive way and as close to home as possible.
• Eliminate the practice of sending people out of area for acute inpatient care
as a result of local acute bed pressures by no later than 2020/21.
Recommendation 13:
• Introduce a range of access and quality standards across mental health. This
includes:
o 2016 - crisis care (under development)
o 2016/17 – acute mental health care (yet to start)
13
Mental Health Forward View – crisis & acute
recommendations (continued, 2/2)
14. 14
National focus in 2016/17 on ‘preparatory’ national work before new money comes in
– the national levers and incentives to support local delivery:
Develop 5x evidence based treatment pathways for crisis and acute care:
• 24/7 UEC mental health liaison in acute hospitals
• 24/7 ‘blue light’ UEC mental health response
• 24/7 community UEC mental health response
• 24/7 UEC response for children and young people
• Acute mental health care pathway
For each of the above:
Referral to treatment pathway, including response times and NICE
quality standards
Implementation guidance
England-wide quality assessment and improvement scheme
England-wide baseline audit and gap analysis
Establish much needed changes to national datasets;
• CCG Improvement and Assessment Framework – Crisis and OATs prominent;
• Development of Sustainability and Transformation plans – new 5 year
approach – including crisis and acute mental health;
• New payment models being developed for mental health and UEC
What next for crisis care & acute care in 2016-18?
15. Organisation
Reliable
Improvement:
Monthly average
August 2015-
January 2016
6 weeks
Completed
Treatment:
Average August
2015- January
2016
Recovery:
Monthly
average
August 2015-
January 2016
Access:
Annualised
Monthly
average
August
2015-
January
2016
At least
60% of
clients
completing
a course of
treatment
A high level of
problem
descriptor
identified at
assessment
January 2016
data only
Wessex
NHS DORSET CCG 70.5% 91.2% 54.8% 15.8% 63.8% 89.8%
NHS FAREHAM AND GOSPORT
CCG 63.9% 83.8% 49.6% 9.0% 65.0% 99.1%
NHS ISLE OF WIGHT CCG 63.5% 88.7% 48.4% 23.1% 75.5% 79.6%
NHS NORTH EAST HAMPSHIRE
AND FARNHAM CCG 62.6% 73.3% 47.7% 15.9% 88.9% 95.0%
NHS NORTH HAMPSHIRE CCG 64.4% 83.0% 51.2% 10.3% 86.9% 99.1%
NHS PORTSMOUTH CCG 70.2% 93.9% 49.7% 16.8% 72.0% 62.4%
NHS SOUTH EASTERN
HAMPSHIRE CCG 66.3% 82.6% 51.4% 8.7% 80.4% 99.1%
NHS SOUTHAMPTON CCG 68.0% 95.2% 50.6% 14.3% 75.0% 95.2%
NHS WEST HAMPSHIRE CCG 66.6% 81.2% 51.3% 9.8% 84.6% 99.0%
15
Performance challenges in achieving national standards for access and
recovery in current services
Adult IAPT: Current Performance
16. Mental Health Forward View commits to:
• Expand IAPT services to meet 25% of need by 2020/21.
o The majority (2/3rds) of the expansion will be ‘Integrated IAPT’
services – co-located in and integrated with physical health
services, and focused on people with co-morbid mental and
physical health conditions. Services should lead to physical health
savings which can be re-invested in further expansion.
o ‘Core’ IAPT services will also expand. Focus on maintaining
quality, improving productivity, support for women in the
perinatal period and continuing to support therapies as
recommended by NICE (e.g. introducing mindfulness based CBT
for depression relapse prevention)
• At least double the number of employment advisors in IAPT services
(led and funded by DH and DWP)
16
IAPT Expansion
17. • Developing new curricula for IAPT practitioners working with people
with long term conditions / Persistent Physical Symptoms
• Developing the service model for new integrated services – planning
to focus attention and investment on primary care
• Initial work with a group of early implementer local health economies
testing and improving the Integrated service model
• NHS England & HEE collaboratively commissioning training for first
wave of new services
• Putting in place the necessary infrastructure to quantify the benefits
and savings of new integrated services
17
National work in 16/17
18. 5%
4% 2%
8% 7%
10%
4%
15%
5%
0%
5%
10%
15%
20%
NHS Dorset
CCG
NHS Fareham
And Gosport
CCG
NHS Isle Of
Wight CCG
NHS North East
Hampshire And
Farnham CCG
NHS North
Hampshire CCG
NHS
Portsmouth
CCG
NHS South
Eastern
Hampshire CCG
NHS
Southampton
CCG
NHS West
Hampshire CCG
IAPT use by BME groups: % of referrals (in quarter) which are for people
of black and minority ethnic groups - Q2 2015/16 (18+ yrs)
3%
2%
1%
4%
3%
4%
1%
8%
2%
0%
1%
2%
3%
4%
5%
6%
7%
8%
9%
NHS Dorset CCG NHS Fareham
And Gosport
CCG
NHS Isle Of
Wight CCG
NHS North East
Hampshire And
Farnham CCG
NHS North
Hampshire CCG
NHS Portsmouth
CCG
NHS South
Eastern
Hampshire CCG
NHS
Southampton
CCG
NHS West
Hampshire CCG
Use of mental health services by BME groups: % of people in contact with
mental health services who are in black and minority ethnic groups -
2014/15 (18+ yrs)
18
How successful is IAPT at meeting a range of needs?
19. 7% 7%
3%
2%
0%
2%
4%
6%
8%
NHS Dorset CCG NHS Fareham And
Gosport CCG
NHS Isle Of Wight
CCG
NHS North East
Hampshire And
Farnham CCG
NHS North
Hampshire CCG
NHS Portsmouth
CCG
NHS South Eastern
Hampshire CCG
NHS Southampton
CCG
NHS West
Hampshire CCG
% Care Programme Approach adults in employment
- Q2 2015/16 (18-69 yrs)
5
10 10
20
0
5
10
15
20
25
Value(£000)
Referrals receiving employment support: Number of referrals finishing a
course of treatment who received employment support (Annual) -
2014/15
19
How successful is IAPT at meeting a range of needs?
20. • Consistent and reliable data in mental health still lags behind other areas.
• The FyFV for mental health sets out a vision for a data and transparency
revolution.
• To support this, in 2016/17 NHS England will be:
o working with the Department of Health and NHS Digital to ensure the new
MHSDS is capturing and reporting the data we need.
o supporting the mental health and dementia intelligence network to develop a
source of high quality data to underpin intelligent commissioning.
o developing a dashboard for mental health to track progress at a national level
and allow benchmarking of services. This will form the basis of the CCG
Improvement and Assessment framework and will help monitor the success of
our national work programmes.
Driving service improvement through transparency
20
Timely and accurate data are essential. We will also be working to remind CCGs
of their contractual responsibility to ensure all the services they are
commissioning are flowing high quality data into the national minimum dataset.
21. • Payment mechanisms can help drive local health economies to improve outcomes
that are of value to people with mental health problems.
• However, over half of mental health trusts are still paid using block contracts,
unrelated to local needs or the quality of care; few providers have moved to contracts
that reward quality and outcomes.
• Our vision is that payment across mental health and dementia should reward access
to evidence based care, integrated care provision, health outcomes and quality,
therefore all payment systems must be transparent and accountable.
To support this, in 2016/17 NHS England will be:
• producing support materials to develop quality and outcome measures which can be
linked to payment - summer
Improving consistency in payment approaches
21
22. • The CCG Improvement and Assessment Framework has been introduced to
empower CCGs to deliver the transformation necessary to achieve the FyFV.
• The focus is on practical support, rather than assurance and monitoring.
• In June 2016 a simple assessment based on a limited number of indicators. The five
measures for mental health are:
• An overall rating for mental health will based on performance against the national
standards for IAPT and EIP, measured against a four-point scale.
• Data from the transformation indicators will be published alongside the overall
rating on MyNHS.
• These measures will be revised for the end 2016/17 to support a more complete
overview of CCG performance in mental health.
National standards Transformation indicators
IAPT recovery rate Children and Adolescent MH
EIP 2 week wait Crisis
Out of Area Treatments
Driving service improvement through transparency
22
23. • Are geographically based and cover health and care needs of the
population
• A place for commissioners and providers to collaboratively develop plans
for a sustainable future over a 5 year period
• Should have multi-agency engagement including health and social care
partners as a minimum
• Include physical and mental health care providers including acute trusts,
primary care and secondary mental health care
• Include specialised services that are provided within that geography (even
when they provide services to a wider population base)
• Cover a larger geography than the usual planning footprints
What are the properties of STPs?
STPs and Mental Health: The Opportunities
23
24. • Invest to save where savings realised beyond the 1 year commissioning
cycle
• Invest to save where savings realised in a different setting (e.g., provide
specialist MH care, save in acute physical health)
• Specialist services that require planning over a geography bigger than a
single CCG
• Delivering care pathways that require a whole system approach (e.g., need
care from primary, secondary physical and mental and social care)
• Investing in preventative or early intervention care to reduce costs of care
later in the cycle
What kinds of activities therefore are best articulated at an STP rather than
a CCG level?
24
25. The CCG improvement and assessment framework transformation indicators to incentivise better
planning and measurement during 2016/17 to eliminate OATs:
1) Has the CCG established a process to monitor mental health out of area placements by bed type,
which includes (at individual patient level)
i how many are made?
ii. the reasons for them?
ii. the duration?
iv. the cost?
2) Does the CCG have a plan in place to reduce all types of mental health out of area placements, with
a specific focus on placements for non-specialist acute mental health beds during 2016/17?
3) Can the CCG demonstrate that it is on track to deliver a reduction in non-specialist acute mental
health bed out of area placements by quarter 4 2016/17?
25
Out of Area Treatments (OATs) – what should be done now?
• Some areas have already managed to eliminate OATs, e.g. Bradford, Sheffield and NE London – by
redesigning the acute care pathway to ensure CRHTTs are able to offer intensive, therapeutic home
treatment as a genuine alternative to admission.
• The money saved with a lower inpatient bed base and fewer costly OATs has been reinvested into
community mental health services to ensure care is delivered in as close to home as possible in the
least restrictive setting, and pressures on the inpatient system are reduced
Editor's Notes
NHS England commissioned North East London Commissioning Support Unit to complete an analysis of the Local Transformation Plans. They completed quantitative analysis and 7 thematic reviews – Outcomes, Participation, Prevention, Eating Disorders, Vulnerable groups, Workforce and Whole Systems.
The quantitative analysis allows us to make a comparison of the information reported by CCGs working with local areas in Wessex compared with England as a whole. There are 5 Local Transformation plans covering Wessex, covering 9 CCGs
Wessex has lower than average NEET and children in poverty
The figures used to compare referrals are reported by 0-17 population rather than of those with a mental health problem. ONS data of mental health problems is measured 5-16 year olds, and there is no reliable data for 0-5 or 17 year olds. Services work across this age range so to be inclusive the analysis is based on population not prevalence
Natioanlly CAMHS accepts 75% of referrals into treatment. In Wessex this is reported as 85%
North East London Commissioning Support developed their own scoring system to look at both the quality and the quantity of data supplied in LTPS during their analysis. The themes were based on those identified in Future in Mind.
Wessex Clinical Network scored highest in many of the themes. However the information NHS England has received in the Quarter 4 tracker which, for this period, asked for information regarding the number of new staff that would be funded by new resources and the numbers of extra children treated above the baseline set for 2014-15 is very limited in its detail
The Transformation money that has been distributed to CCGs is to help them build capacity and capability in the both Eating Disorders, to create dedicated teams, and in generic CAMHS service. What we would expect to see reflected in this and the next slide is where the money is being spent. Next year programme finance tracking will require CCgs to set out their spend in detail, but questions are being asked now about whether or not the funds have been allocated to CYP MH
It is possible that Portsmouth are using the total funds from the Spring Budget and ED to staff the ED team
Eating Disorders is a condition that can kill. The referral to treatment standard is based on strong evidence that early intervention improves outcomes and reduces costs. In 2016 we will be setting the trajectory to that by 2020 95% of all CYP with ED are seen within a week if urgent and 4 weeks if routine.
Any funds not used for ED from the ED monies should be used fro Crisis and Self Harm. I look forward to greatly improved ED and Crisis services in Wessex
Isle of Wight CCG reported in their Local Transformation plan that they are currently meeting the 4 week target of the Access and Wait Standard in 91.7% of cases.
Current work focus and highlights
Increasing MBU capacity – reviewing capacity in existing units, procurement and building 3 new units
Perinatal clinical networks – establishing networks in all regions to support development of clinical pathways and of local services based on need.
Workforce capacity and capability – develop capacity and competency to deliver project objectives in perinatal MH transformation across workforce groups. Align with wider children’s, maternity and IAPT workforce development approaches.
Developing areas
Data and metrics – to set baselines, identify need and track progress
Commissioning development (community specialist teams) –analysis and support for strategic system planning to extend availability of specialist community support, developing guidance to support transformation, piloting , testing and evaluating innovative models at pace.
Levers and incentives – to develop key metrics for CCGs and providers and to identify other incentive models (e.g payment systems) to drive change
New care models – to explore, test and evaluate collaborative commissioning modelsAnd underpinning all work areas:
Communications and engagement – to raise awareness, share progress, co-produce solutions, involve women and families with lived experience.
‘WedBeds’ is a national bed availability database. It is due to be piloted with all MBU’s from July 2016 and will go live later this year.
Note that other CCG in South East region (40 CCGs) has data on employment. This suggest that Wessex has poor data quality this instance (in comparison to other CCGs within the same region). The data is from Fingertips.
MHSDS implemented in January, 90 Provider organisations are regularly submitting data
We are working with partner organisation (DH, HSCIC, NHS I) to drive quality.
Most adult providers are submitting data, however the process is new for CAMHS and improvement required
The MHSDS will in due course (when data quality assured) be used to monitor compliance of MH AWT standard. In the interim NHS E are running a bespoke EIP AWT collection. In March nationally 64.4% of patients started treatment within two weeks (720 out of 1,118 patients)